Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers - a Pilot Study

Completed · Phase 4

Conditions studied: Infraorbital Hollows

In brief

The primary objective of this study is to determine the efficacy and longevity of the use of Restylane® and Perlane® in combination for the rejuvenation of the infraorbital hollows and to measure patient satisfaction with this treatment

Key facts

Study ID

NCT00852241

Run by

The Cleveland Clinic

People needed

18

Starts

2009-02-01

Expected to finish

2009-09-01

Last updated by the study team

2018-03-12

Who can join

Age: 18 and older, up to 70. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Age 18 years and older
• No significant medical illness
• Subjects with the willingness and ability to understand and provide informed consent

You may not qualify if…

• Under 18 years of age
• Pregnancy or Lactation
• Subjects who have had previous surgical treatment of the lower eyelid area or previous use of filling agents in the under eye area
• Subjects with a known allergy to the components in Restylane® or Perlane®
• Subjects currently taking blood thinners or who have had chemotherapy or radiation within the last 6 months
• Subjects with liver/kidney disease or compromise or who are immunocompromised
• Subjects with a known susceptibility to keloid formation or hypertrophic scarring
• Subjects with an open, non-healing sore or infection near the site of injections
• Subjects who are unable to understand the protocol or to give informed consent
• Subjects with mental illness

Where it is running

• Cleveland Clinic Foundation — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.